- RYAH Group is a digital healthcare analytics and technology company focused on developing tools that provide patients and doctors with the ability to accurately manage the intake in plant-based treatment
- The company recently revealed its participation at the Wall Street Reporter’s ‘Next Super Stock’ livestream conference held on September 23, 2021
RYAH Group (CSE: RYAH) is a leading digital health care analytics and technology company with a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. The company specializes in developing volume-control IoT devices to provide accurate volume control and management for various medical purposes.
RYAH Group’s management recently revealed their attendance at the Wall Street Reporter’s “Next Super Stock” livestream conference, held on September 23, 2021 (https://cnw.fm/BsXn0).
Wall Street Reporter’s Next Super Stock conference (https://cnw.fm/apMzy) features select companies with major near-term catalysts in place to drive transformational growth (and stock appreciation) in the months ahead.
Due to the ‘Next Super Stock’ conference’s track record showcasing companies which have enjoyed exponential increases in the weeks following the conference, hundreds of institutional investors habitually attend the meeting in anticipation of discovering the next big breakthrough.
RYAH Group’s current product portfolio incorporates an ecosystem of IoT products, each consisting of three elements: the device, the medicine-carrying component, and the mobile application. The product line currently includes a Smart Dry-Herb Inhaler in the commercial stage, a Smart Transdermal Patch in the production stage, and a Smart Liquid Dispensing Pen in the prototype stage.
The RYAH Inhaler is the first dry-herb inhaler that allows users to track and control how much is inhaled, providing consistent and predictable results. This inhaler connects with the RYAH Health App, which features stat-tracking and pre-sets for temperatures and volumes. All of these features are customizable to individual needs and doctor recommendations.
The RYAH Smart Transdermal Patch is a lightweight, reusable, mobile-controlled patch used for site-specific therapies. The Patch is an Electronic Topical Delivery Patch system intended for recommendation and administration by pain relief professionals and physical and occupational therapists. The patch data and heating element are completely IoT and controlled by RYAH’s proprietary smartphone applications, allowing on-demand scheduling and ‘boosting’ medicine release.
RYAH’s Smart Liquid Dispensing Pen is an app-controlled liquid dispenser designed to provide a precise mix of up to three medicine components to create an ‘entourage effect,’ enabling customized, wide-spectrum recommendation opportunities by licensed clinicians.
RYAH Group’s product suite of precision intake and volume management devices provides patients and medical practitioners with a practical toolkit to abide by volume control guidelines safely and accurately. In addition, detailed analytics provided by these RYAH devices help determine which intake volumes are working and what needs adjusting, along with accurately depicting a patient’s progress in their treatment.
For more information, visit the company’s website at www.RYAHGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://cnw.fm/RYAH
CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CanadianCannabisWire.com
Do you have questions or are you interested in working with CNW? Ask our Editor
CanadianCannabisWire is part of the InvestorBrandNetwork.